0001683168-26-002958
SEC filingSativus Tech Corp. reported deeper operating and net losses in FY2025, with operating income declining 10.6% YoY to -$1.1M and net income falling 27.8% to -$869K — reflecting continued pre-commercial investment without revenue generation.
Operating income was -$1,060,000 for FY2025, compared to -$958,000 for FY2024 — a 10.6% deterioration on a percentage basis. This decline is attributable to an increase in the net loss of the Company, as confirmed in management’s commentary. The business continues to invest in R&D and infrastructure to support Saffron Tech’s mission to create large-scale saffron production using vertical farming technology for beauty, wellness, and pharmaceutical applications. With the proof of concept pilot site poised for launch in the upcoming months, these expenses reflect deliberate, stage-appropriate investment rather than operational inefficiency.
Net cash used in operating activities was -$701,000 in FY2025, versus -$488,000 in FY2024. This increase in cash outflow aligns with the larger net loss and confirms that no material operating cash inflows occurred during the period. Capital expenditures were $3,000 in FY2025 — a dramatic reduction from $269,000 in FY2024 — indicating completion of major facility-related investments at the Ganei Tal site and a shift toward operational readiness. Free cash flow, defined as net cash provided by operating activities less capital expenditures, was therefore -$704,000. This figure reflects the totality of cash consumption during the year, with no offset from asset disposals, financing proceeds, or investing inflows.